Keyphrases
Hematopoietic Stem Cell Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
98%
Nonmyeloablative
51%
Autoimmune Disease
46%
Cyclophosphamide
28%
Systemic Lupus Erythematosus
27%
Multiple Sclerosis
26%
Graft-versus-host Disease (GvHD)
26%
Systemic Sclerosis
23%
Conditioning Regimen
21%
Remission
20%
Transplantation
19%
Embryonic Stem Cells
19%
Bone Marrow Transplantation
18%
Hematopoietic Stem Cells
18%
Stem Cells
17%
Type 1 Diabetes Mellitus (T1DM)
17%
Marrow
16%
Granulocyte Colony-stimulating Factor (G-CSF)
16%
Multidrug Resistance
15%
Peripheral Blood
15%
Allogeneic
14%
Syngeneic
14%
Relapsing-remitting multiple Sclerosis
13%
Pretransplant
13%
Peripheral Blood Stem Cells
12%
T Cells
11%
Disease-modifying Therapy
11%
Rheumatoid Arthritis
11%
Antithymocyte Globulin
11%
Experimental Autoimmune Encephalomyelitis
10%
Clinical Outcomes
10%
Donor Lymphocytes
10%
Type I Diabetes
10%
Treatment-related Mortality
10%
Haemopoietic Stem Cell Transplantation
9%
Crohn's Disease
9%
Thymidine Kinase Gene
9%
Herpes Simplex Virus Thymidine Kinase
9%
Mixed chimerism
9%
Adoptive Immunotherapy
9%
Myeloablative Regimen
8%
Leukemia
8%
Lupus
8%
Progressive multiple Sclerosis
8%
Central Nervous System
8%
Lymphocytes
8%
CD34+
8%
Remission Induction
8%
Expanded Disability Status Scale
8%
Alemtuzumab
8%
Total Body Irradiation
8%
Disease Progression
7%
Immune System
7%
Stem Cell Transplantation
7%
Immune Suppression
7%
Myeloablative
7%
Refractory Crohn's Disease
7%
Crohn's Disease Activity Index
7%
Acute Myocardial Infarction
7%
Feeder Layer
7%
Newly Diagnosed
7%
Cutaneous T-cell Lymphoma
7%
Cardiac Function
6%
Engraftment
6%
Donor Lymphocyte Infusion
6%
Autoimmune
6%
Brazil
6%
Hematopoietic Stem Cell Therapy
6%
Multidrug Resistance Protein 1 (MDR1)
6%
Antiphospholipid Syndrome
6%
Myocardium
6%
Rat Liver
6%
Clinical Trials
6%
CD34
6%
Stem Cell-derived
5%
Gene Expression
5%
P-glycoprotein (P-gp)
5%
Quality of Life
5%
Neurological Impairment
5%
Bone Marrow
5%
Insulin Independence
5%
Randomized Trial
5%
Major Histocompatibility Complex
5%
Long-term Remission
5%
Immune Reconstitution
5%
Regulatory T (Treg) Cells
5%
Immunosuppression
5%
Gene Family
5%
Autologous HSCT
5%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
57%
Autologous Hematopoietic Stem Cell Transplantation
49%
Diseases
27%
Autoimmune Disease
27%
Systemic Lupus Erythematosus
25%
Hematopoietic Cell
25%
Multiple Sclerosis
21%
Nonmyeloablative Stem Cell Transplantation
21%
Systemic Scleroderma
19%
Insulin Dependent Diabetes Mellitus
18%
Stem Cell Therapy
17%
Embryonic Stem Cell
16%
Lymphocyte
15%
Graft Versus Host Reaction
15%
Immunosuppressive Treatment
14%
Stem Cell
14%
Bone Marrow Transplantation
13%
Cyclophosphamide
12%
Allogeneic Hematopoietic Stem Cell Transplantation
11%
Conditioning
11%
Leukemia
10%
Thymidine Kinase
9%
Herpes Simplex
9%
Adoptive Immunotherapy
9%
Lupus Erythematosus
8%
Quality of Life
8%
Spontaneous Remission
7%
Autoimmunity
7%
Diabetes
7%
Cutaneous T Cell Lymphoma
7%
Crohn's Disease
7%
Feeder Cell
7%
Donor Lymphocyte Infusion
6%
Acute Heart Infarction
6%
Drug Megadose
6%
Heart Function
6%
Engraftment
6%
Myocardium
6%
Rheumatoid Arthritis
6%
Diabetes Mellitus
6%
Antiphospholipid Syndrome
6%
Nurse
6%
Inflammatory Arthritis
6%
Peripheral Blood Stem Cell
5%
Whole Body Radiation
5%
Cell Therapy
5%
Malignant Neoplasm
5%
Expanded Disability Status Scale
5%
Thymocyte Antibody
5%
C-Peptide
5%
Graft Versus Tumor Effect
5%
Granulocyte Colony Stimulating Factor
5%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
67%
Autologous Hematopoietic Stem Cell Transplantation
62%
Autoimmune Disease
43%
Conditioning
30%
Hematopoietic Cell
29%
Multiple Sclerosis
27%
Systemic Scleroderma
22%
Cyclophosphamide
21%
Systemic Lupus Erythematosus
20%
Stem Cell Transplantation
19%
Nonmyeloablative Stem Cell Transplantation
18%
T Cell
15%
Graft-Versus-Host Disease
14%
Crohn's Disease
12%
Inflammatory Arthritis
10%
Embryonic Stem Cell
10%
Lymphocyte
10%
Regulatory T Cell
10%
Lupus Erythematosus
10%
Peptides
9%
CD34
8%
Bone Marrow Transplantation
8%
Insulin
8%
Anti-Thymocyte Globulin
8%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Granulocyte Colony-Stimulating Factor
7%
Syngenic
7%
Engraftment
7%
Peripheral Blood Stem Cell
7%
Stem Cell
7%
Alemtuzumab
6%
Immunosuppression
6%
T Cell Receptor
6%
Autoimmunity
6%
Expanded Disability Status Scale
6%
Adoptive Immunotherapy
6%
Experimental Autoimmune Encephalomyelitis
6%
Diabetes Mellitus Type 1
6%
Antiphospholipid Syndrome
6%
Central Nervous System
6%
Drug Megadose
5%
Immune System
5%
Major Histocompatibility Complex
5%
CD4
5%
Immunosuppressive Drug
5%
Immunotherapy
5%
Cytotoxic T-Cell
5%